Results 81 to 90 of about 8,864 (209)

Terapia com [177Lu – Dota0 – Tyr3]–Octreotate (177Lu-Dotatate) em Pacientes com Tumores Avançados de Origem Neuroendócrino: Experiência Inicial e Resultados Preliminares

Revista Ciencias de la Salud, 2017
Objetivo: mostrar a experiência inicial e os resultados preliminares da terapia com [177Lu – Dota0 – Tyr3] –Octreotate (177Lu-Dotatate) em pacientes tratados na nossa instituição, devido a que a experiência derivada desta prática em países latino ...
Víctor Marín Oyaga, Claudia Gutiérrez Villamil, Arturo Mejía López, Alex Valenzuela Rincón, Gabriel Sánchez de Guzmán, José Sinay Arévalo Leal   +5 more
doaj   +1 more source

Primary Neuroendocrine Carcinoma of the Breast: A Diagnostic Challenge and Case Report

Cancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Primary neuroendocrine carcinoma of the breast (NECB) represents an exceedingly rare entity, comprising less than 0.5% of all breast carcinomas and approximately 1% of all neuroendocrine neoplasms. The 2019 WHO classification defines NECB as tumors expressing neuroendocrine markers in > 90% of tumor cells with morphological features
Hamid Zeinali Nezhad, Shima Yaghoobi, Nazanin Zeinali Nezhad, Amirhossein Shahpar, Abtin Malekpour Afshar, Mina Bagherijamebozorgi   +5 more
wiley   +1 more source

Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study.

, 2023
20.500.12530/87897Peptide receptor radionuclide therapy (PRRT) is one of the most promising therapeutic strategies in neuroendocrine neoplasms (NENs). Nevertheless, its role in certain tumor sites remains unclear.
Garcia-Alonso, Pilar, Muros, Maria Angustias, Llana, Belén, Percovich, Juan Carlos, Carmona-Bayonas, Alberto, Belló, Pilar, Pubul, Virginia, García-Cañamaque, Lina, Riesco, Maria Carmen, Custodio, Ana, Rodeño, Emilia, Jimenez-Fonseca, Paula, Castellón, Maribel, Hernando, Jorge, Repetto, Alexandra, Cano, Juana María, Mitjavila, Mercedes, Garcia-Burillo, Amparo, Arbizu, Javier, Vercher-Conejero, Jose Luis, Estorch, Montserrat, Gajate, Pablo, Miguel, Maria Begoña, Balaguer-Muñoz, David   +23 more
core   +1 more source

Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial)

BMC Gastroenterology, 2018
Background Neuroendocrine tumours (NET) consist of a heterogeneous group of neoplasms with various organs of origin. At diagnosis 21% of the patients with a Grade 1 NET and 30% with a Grade 2 NET have distant metastases.
Arthur J. A. T. Braat, Dik J. Kwekkeboom, Boen L. R. Kam, Jaap J. M. Teunissen, Wouter W. de Herder, Koen M. A. Dreijerink, Rob van Rooij, Gerard C. Krijger, Hugo W. A. M. de Jong, Maurice A. A. J. van den Bosch, Marnix G. E. H. Lam   +10 more
doaj   +1 more source

Survival outcomes and prognostic factors of gastric carcinoma with neuroendocrine differentiation

International Journal of Cancer, Volume 158, Issue 9, Page 2209-2218, 1 May 2026.
What's new? Although gastric carcinoma with neuroendocrine differentiation (GCNED) is associated with more aggressive features than conventional GC, its prognosis and survival remain poorly defined. To better understand survival patterns, the authors of the present study examined clinicopathological and prognostic features of GCNED patients following ...
Jinjin Li, Chenglong Wang, Yifan Shen, Zhen Huang, Jun Zhang, Siqi Rao, Youde Cao, Jiang Min   +7 more
wiley   +1 more source

Czy nefrotoksyczność po PRRT jest nadal poważnym problemem klinicznym? Analiza stopnia uszkodzenia nerek po terapii znakowanymi izotopowo analogami somatostatyny z zastosowaniem 90Y-DOTATATE i 90Y/177Lu-DOTATATE [PDF]

, 2013
Introduction: The kidneys play an essential role in PRRT. The infusion of amino acids could reduce uptake in the kidney of radiolabelled peptides. The purpose of this study was to determine the extent of kidney damage post PRRT.
Mikołajczak, Renata, Sowa-Staszczak, Anna, Królicki, Leszek, Kunikowska, Jolanta, Pawlak, Dariusz, Hubalewska-Dydejczyk, Alicja   +5 more
core  

Additional file 1 of Lymphopenia during 177Lu-DOTATATE therapy leading to recurrence of tuberculosis: a case report

, 2022
Additional file 1: Fig. S1. 68Ga-DOTATATE PET/CT image (SUV scale: 0–12.5 g/mL): MIP images a and e before PRRT and after PRRT; b), c) and d) axial slices CT, Fused PET/CT and CE-CT (Top images=after PRRT). Fig. S2.
John O. Prior (5100761), Michael Da Mota (15219059), Maria Firsova (15219065), Sarah Boughdad (15219056), Mélanie Mendes De Carvalho (15219062), Niklaus Schaefer (5100758)   +5 more
core   +1 more source

Comparison of Two Types of Amino Acid Solutions on 177Lu-Dotatate Pharmacokinetics and Pharmacodynamics in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors

, 2022
International audienceBackground: 177Lu-Dotatate is used in the treatment of somatostatin-receptor-positive inoperable progressive gastroenteropancreatic neuroendocrine tumors. A co-infusion of amino acids (AAs) is administered to prevent renal toxicity.
Dierickx, Lawrence, Lambert, Marie, Courbon, Frédéric, Brillouet, Séverine, Chatelut, Étienne   +4 more
core   +1 more source

A case report of acute carcinoid heart failure during lutetium-177 dotatate–triapine treatment for well-differentiated neuroendocrine tumors

Frontiers in Oncology
IntroductionWell-differentiated neuroendocrine tumors (NETs) have a high indolent local progression rate when resistance develops to biologic or cytotoxic chemotherapy.
Aman Chauhan, Elise C Kohn, S Percy Ivy, Jill M Kolesar, Rakhi Modak, Susanne Arnold, Lowell Anthony, William E. Carson, Nathan R Shelman, Charles A Kunos   +9 more
doaj   +1 more source

Abstracts

Molecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source